Global Smart Insulin Pens Market 2022-2028

August 2022 | 64 pages | ID: GF46CF880E13EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the global smart insulin pens market is poised to grow by USD 73 million during 2022-2028, progressing at a CAGR of 10.3% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart insulin pens market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart insulin pens industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, distribution channel, and region. The global market for smart insulin pens can be segmented by product: connecting device, smart pen. Smart insulin pens market is further segmented by distribution channel: hospitals and pharmacies, online. Based on region, the smart insulin pens market is segmented into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By product:

• connecting device
• smart pen

By distribution channel:

• hospitals and pharmacies
• online

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The global smart insulin pens market report offers detailed information on several market vendors, including Companion Medical, Inc. (Medtronic plc), Diamesco Co., Ltd., Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH E-Health Technologies, Novo Nordisk A/S, pendiq GmbH, Ypsomed Holding AG, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global smart insulin pens market.
• To classify and forecast the global smart insulin pens market based on product, distribution channel, region.
• To identify drivers and challenges for the global smart insulin pens market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart insulin pens market.
• To identify and analyze the profile of leading players operating in the global smart insulin pens market.

Why Choose This Report

• Gain a reliable outlook of the global smart insulin pens market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Connecting device
Smart pen

PART 6. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL

Hospitals and pharmacies
Online

PART 7. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 8. KEY COMPANIES

Companion Medical, Inc. (Medtronic plc)
Diamesco Co., Ltd.
Digital Medics Pty Ltd.
Eli Lilly and Company
Emperra GmbH E-Health Technologies
Novo Nordisk A/S
pendiq GmbH
Ypsomed Holding AG
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER